Beijing Allcure Medical Technology
Beijing Allcure Medical Technology Co., Ltd. applies mdaccAutoPlan® radiotherapy plan algorithm
About Beijing Allcure Medical Technology
Beijing Allcure Medical Technology Co., Ltd. is a healthcare technology company established in 2012, operating as a subsidiary of Concord Medical Services Holdings Limited. The company was founded by Zheng Cheng, who previously served as the Chief Operating Officer of Concord Medical, an operator of diagnostic and oncology radiological centers in China. His experience in this specialized medical field directly informs the company's focus.
Allcure Medical is centered on improving the survival rates of tumor patients in China by leveraging technology to standardize and enhance cancer treatment, particularly in the field of radiation oncology. The company provides a suite of comprehensive services to hospitals, including the construction of tumor radiotherapy software systems, supply of hardware equipment, and technical support services. Its business model appears to be B2B, serving famous tumor hospitals and hundreds of primary hospitals across China.
The core of Allcure's offering is its "Accurate Cloud Radiotherapy" technology platform. This platform utilizes the mdaccAutoPlan radiotherapy algorithm, cloud computing, and big data to develop solutions like Accurate Cloud Quality Control™ and Accurate Cloud Plan™. These tools aim to automate and standardize the creation of radiotherapy treatment plans, providing powerful support for the cooperative management of tumor diagnosis and treatment nationwide. By connecting high-quality radiotherapy resources from top-tier national hospitals with primary-level hospitals, Allcure facilitates a system of graded diagnosis and treatment.
Source: Dealroom company dataNews
Open roles
Beijing Allcure Medical Technology in the Dongcheng District ecosystem
The Beijing Allcure Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- LCLotus Venture Capital
- MCMAGS Capital
- CGChina Capital Investment Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Allcure Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Allcure Medical Technology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


